TFX logo

TFX

Teleflex IncorporatedNYSEHealthcare
$117.81-0.52%ClosedMarket Cap: $5.21B

As of 2026-04-06

Valuation

View Details

P/E (TTM)

PEG

P/B

1.67

P/S

1.76

EV/EBITDA

68.44

DCF Value

$154.75

FCF Yield

4.7%

Div Yield

1.2%

Margins & Returns

Gross Margin

53.3%

Operating Margin

9.7%

Net Margin

-30.6%

ROE

-23.7%

ROA

-29.0%

ROIC

4.3%

Financials

View All
PeriodRevenueNet IncomeEPS
Q4 2025$569.0M$-714.3M$-16.15
FY 2025$1.99B$-905.6M$-20.25
Q3 2025$913.0M$-408.9M$-9.24
Q2 2025$780.9M$122.6M$2.77

Analyst Ratings

View All
Raymond JamesOutperform
2026-03-27
RBC CapitalSector Perform
2026-02-27
Wells FargoEqual Weight
2026-02-27
NeedhamBuy
2026-02-26
Truist SecuritiesHold
2025-12-18

Trading Activity

Insider Trades

View All
Logue Daniel V.officer: CVP, General Counsel & Secty
SellThu Mar 05
Logue Daniel V.officer: CVP, General Counsel & Secty
SellThu Mar 05
Logue Daniel V.officer: CVP, General Counsel & Secty
SellThu Mar 05
Logue Daniel V.officer: CVP, General Counsel & Secty
SellThu Mar 05
Deren Johnofficer: Executive Vice President & CFO
SellThu Mar 05

Company Info

Sector

Healthcare

Industry

Country

US

Exchange

NYSE

Beta

0.83

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.

Peers